Home › Down Syndrome › Tennessee › Nashville
Down Syndrome clinical trials in Nashville, TN
5 studies for Down Syndrome are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 2
- The Children's Hospital at TriStar Centennial, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
RecruitingObservational study
- Vanderbilt University/Ingram Cancer Center, Nashville
Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition
RecruitingPhase 2Healthy volunteers welcome
- Vanderbilt University Medical Center Clinical Research Center, Nashville
Drumming Lessons' Influence on Children With Down Syndrome
Recruiting
- Vanderbilt University, Nashville
Trial-Ready Cohort-Down Syndrome (TRC-DS)
RecruitingObservational study
- Vanderbilt University Medical Center Center for Cognitive Medicine, Nashville
About Down Syndrome
About 1 in 700 babies are born with the birth defect known as Down Syndrome. Learn about the different Down Syndrome types and related health issues.
More about Down Syndrome on MedlinePlus
Down Syndrome trials in other cities
- Aurora, CO7 studies
- Durham, NC6 studies
- Houston, TX6 studies
- Phoenix, AZ6 studies
- Cincinnati, OH5 studies
- Cleveland, OH5 studies
- Kansas City, KS5 studies
- Philadelphia, PA5 studies
- Ann Arbor, MI5 studies
- Orlando, FL5 studies
- Birmingham, AL4 studies
- San Diego, CA4 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer96 studies
- Breast Cancer79 studies
- Metastatic Cancer69 studies
- Colorectal Cancer68 studies
- Cancer (all types)64 studies
- Ovarian Cancer48 studies
- Prostate Cancer43 studies
- Pancreatic Cancer40 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Endometrial Cancer37 studies
- Melanoma32 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.